The DOI matches its Crossref record; 314 of the 314 references it cites were found in a registry or an index.
Targeting telomeres and telomerase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–314 of 314
Isothiazolone Derivatives Selectively Inhibit Telomerase from Human and Rat Cancer Cells in Vitro
Hayakawa, N., Nozawa, K., Ogawa, A., Kato, N., Yoshida, K., Akamatsu, K., Tsuchiya, M., Nagasaka, A., & Yoshida, S. (1999) · Biochemistry · doi:10.1021/bi982829k · Cited by 90
Senescence As an Anticancer Mechanism
Hornsby, P. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3101 · Cited by 90
Compton, S. A., Choi, J.-H., Cesare, A. J., Özgür, S., & Griffith, J. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3672 · Cited by 90
A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT
Cerone, M. A., Autexier, C., Londoño‐Vallejo, A., & Bacchetti, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208934 · Cited by 89
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas, M. A., Reis, R. J. S., Akiyama, M., Koley, H., Chauhan, D., Hideshima, T., Goyal, R. K., Hurley, L. H., Anderson, K. C., & Munshi, N. C. (2003) · PubMed · Cited by 88
Ouchi, H., Ishiguro, H., IKEDA, N., Hori, M., Kubota, Y., & Uemura, H. (2005) · International Journal of Urology · doi:10.1111/j.1442-2042.2004.00973.x · Cited by 88
Interaction of an Acridine Dimer with DNA Quadruplex Structures
Alberti, P., Ren, J., Teulade‐Fichou, M., Guittat, L., Riou, J., Chaires, J. B., Hélène, C., Vigneron, J., Lehn, J., & Mergny, J. (2001) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2001.10506758 · Cited by 88
Self-citation2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai, S., Kondo, Y., Koga, S., Komata, T., Barna, B. P., & Kondo, S. (2000) · PubMed · Cited by 88
Brassart, B., Gómez, D., Cian, A. D., Boujemaa‐Paterski, R., Montagnac, A., Khuong‐Huu, Q., Temime‐Smaali, N., Trentesaux, C., Mergny, J., Guéritte, F., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.036574 · Cited by 87
Self-citationChang, C., Kuo, I., Lin, J., Lu, Y., Chen, C., Back, H., Lou, P., & Chang, T. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490100 · Cited by 85
Yokoyama, M. (2003) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.09.023 · Cited by 85
Specific targeting of insect and vertebrate telomeres with pyrrole and imidazole polyamides
Maeshima, K., Janssen, S., & Laemmli, U. K. (2001) · The EMBO Journal · doi:10.1093/emboj/20.12.3218 · Cited by 84
Wang, P., Ren, L., He, H., Liang, F., Zhou, X., & Tan, Z. (2006) · ChemBioChem · doi:10.1002/cbic.200600036 · Cited by 83
Wang, E. S., Wu, K., Chin, A. C., Chen‐Kiang, S., Pongracz, K., Gryaznov, S. M., & Moore, M. A. S. (2003) · Blood · doi:10.1182/blood-2003-02-0546 · Cited by 83
Potent Inhibition of Human Telomerase by Nitrostyrene Derivatives
Kim, J., Kim, J. H., Lee, G. E., Lee, J. E., & Chung, I. K. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1117 · Cited by 83
Sissi, C., Lucatello, L., Krapcho, A. P., Maloney, D. J., Boxer, M. B., Camarasa, M. V., Pezzoni, G., Menta, E., & Palumbo, M. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.029 · Cited by 82
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer
Nanni, S., Narducci, M., Pietra, L. D., Moretti, F., Grasselli, A., Carli, P. D., Sacchi, A., Pontecorvi, A., & Farsetti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215552 · Cited by 81
Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies?
Pendino, F., Tárkányi, I., Dudognon, C., Hillion, J., Lanotte, M., Aradi, J., & Segal-Bendirdjian, E. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776056482 · Cited by 80
Cerone, M. A., Londoño‐Vallejo, A., & Autexier, C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0033 · Cited by 79
TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells
Biroccio, A., Rizzo, A., Elli, R., Koering, C.-E., Belleville, A., Benassi, B., Leonetti, C., Stevens, M. F. G., D’Incalci, M., Zupi, G., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.03.010 · Cited by 79
Cheng, A., Shin‐ya, K., Wan, R., Tang, S., Miura, T., Tang, H., Khatri, R. G., Gleichman, M., Ouyang, X., Liu, D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0590-07.2007 · Cited by 78
Uziel, O., Fenig, E., Nordenberg, J., Beery, E., Reshef, H., Sandbank, J., Birenbaum, M., Bakhanashvili, M., Yerushalmi, R., Luria, D., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602592 · Cited by 78
Induction of Apoptosis by Telomere 3′ Overhang-Specific DNA
Eller, M. S., Puri, N., Hadshiew, I., Venna, S. S., & Gilchrest, B. A. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5531 · Cited by 78
Using Natural Product Inhibitors to Validate Hsp90 as a Molecular Target in Cancer
Neckers, L. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777811979 · Cited by 77
Potent inhibition of human telomerase by helenalin
Huang, P., Yeh, Y., & Wang, T. V. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.045 · Cited by 77
Antiadhesive Effects of GRN163L—An Oligonucleotide N3′→P5′ Thio-Phosphoramidate Targeting Telomerase
Jackson, S. R., Zhu, C.-H., Paulson, V., Watkins, L., Dikmen, Z. G., Gryaznov, S. M., Wright, W. E., & Shay, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2306 · Cited by 72
Rossetti, L., Franceschin, M., Schirripa, S., Bianco, A., Ortaggi, G., & Savino, M. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.061 · Cited by 72
Burnworth, B., Arendt, S., Muffler, S., Steinkraus, V., Bröcker, E., Birek, C., Hartschuh, W., Jauch, A. S., & Boukamp, P. (2007) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.11.002 · Cited by 72
Martins, C., Gunaratnam, M., Stuart, J. W., Makwana, V., Greciano, O., Reszka, A. P., Kèlland, L. R., & Neidle, S. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.056 · Cited by 71
G-Quadruplexes Induce Apoptosis in Tumor Cells
Qi, H., Lin, C., Fu, X., Wood, L. M., Liu, A. A., Tsai, Y.-C., Chen, Y., Barbieri, C. M., Pilch, D. S., & Liu, L. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1225 · Cited by 71
Chang, J. T., Lu, Y.-C., Chen, Y., Tseng, C.-P., Chen, Y.-L., Fang, C.-W., & Cheng, A.-J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603008 · Cited by 71
Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro
Guittat, L., Cian, A. D., Rosu, F., Gabelica, V., Pauw, E. D., Delfourne, E., & Mergny, J. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.04.023 · Cited by 71
Self-citationTelomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70
A role for WRN in telomere-based DNA damage responses
Eller, M. S., Liao, X., Liu, S., Hanna, K., Bäckvall, H., Opresko, P. L., Bohr, V. A., & Gilchrest, B. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607332103 · Cited by 70
Youds, J. L., O’Neil, N. J., & Rose, A. M. (2006) · Genetics · doi:10.1534/genetics.106.056879 · Cited by 70
Neomycin-capped aromatic platforms: quadruplex DNA recognition and telomerase inhibition
Kaiser, M., Cian, A. D., Sainlos, M., Renner, C., Mergny, J., & Teulade‐Fichou, M. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b516378a · Cited by 68
Self-citationTelomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells
Aoki, H., Iwado, E., Eller, M. S., Kondo, Y., Fujiwara, K., Li, G., Hess, K. R., Siwak, D. R., Sawaya, R. A., Mills, G. B., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-6941com · Cited by 66
A Novel Regulator of Telomerase
Rosenberger, S. F., Thorey, I. S., Werner, S., & Boukamp, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610529200 · Cited by 66
Porphyrin–aminoquinoline conjugates as telomerase inhibitors
Maraval, A., Franco, S., Vialas, C., Pratviel, G., Blasco, M. A., & Meunier, B. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b211634k · Cited by 66
Structure-activity relationships among guanine-quadruplex telomerase inhibitors
Neidle, S., Harrison, R. J., Reszka, A. P., & Read, M. A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00065-0 · Cited by 65
Richter, T., Saretzki, G. C., Nelson, G., Melcher, M., Olijslagers, S., & von Zglinicki, T. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.02.003 · Cited by 64
Fletcher, T. M., Cathers, B. E., Ravikumar, K. S., Mamiya, B. M., & Kerwin, S. M. (2001) · Bioorganic Chemistry · doi:10.1006/bioo.2000.1194 · Cited by 64
hSnm1B Is a Novel Telomere-associated Protein
Freibaum, B. D., & Counter, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600038200 · Cited by 64
Hoare, S. F., Bryce, L., Wisman, G. B. A., Burns, S., Going, J. J., van der Zee, A., & Keith, W. N. (2001) · PubMed · Cited by 64
Falchetti, A., Franchi, A., Bordi, C., Mavilia, C., Masi, L., Cioppi, F., Recenti, R., Picariello, L., Marini, F., Monte, F. D., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041123 · Cited by 62
Induction of a p95/Nbs1‐mediated S phase checkpoint by telomere 3′ overhang specific DNA
Eller, M. S., Li, G., Firoozabadi, R., Puri, N., & Gilchrest, B. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0197com · Cited by 61
T‐oligos augment UV‐induced protective responses in human skin
Arad, S., Konnikov, N., Goukassian, D. A., & Gilchrest, B. A. (2006) · The FASEB Journal · doi:10.1096/fj.06-5964fje · Cited by 60
Telomerase Inhibition Using Azidothymidine in the HT-29 Colon Cancer Cell Line
Brown, T. A., Sigurdson, E. R., Rogatko, A., & Broccoli, D. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.032 · Cited by 60
Telomerase RNA Levels Limit the Telomere Length EquilibriumPreprint
Greider, C. W. (2006) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2006.71.063 · Cited by 60
Kim, J. H., Kim, J. H., Lee, G. E., Kim, S. W., & Chung, I. K. (2003) · Biochemical Journal · doi:10.1042/bj20030363 · Cited by 59
Gómez, D., Aouali, N., Londoño‐Vallejo, A., Lacroix, L., Mégnin-Chanet, F., Lemarteleur, T., Douarre, C., Shin‐ya, K., Mailliet, P., Trentesaux, C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308440200 · Cited by 59
Self-citationMolecular Modelling and Cytotoxicity of Substituted Anthraquinones as Inhibitors of Human Telomerase
Cairns, D., Michalitsi, E., Jenkins, T. C., & Mackay, S. P. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00337-6 · Cited by 57
Treatment of bladder cancer cells in vitro and in vivo with 2–5A antisense telomerase RNA
Koga, S., Kondo, Y., Komata, T., & Kondo, S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301449 · Cited by 57
Woo, H. J., Lee, S., Choi, B. T., Park, Y., & Choi, Y. H. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.02.004 · Cited by 56
The p23 molecular chaperone promotes functional telomerase complexes through DNA dissociation
Toogun, O. A., Zeiger, W., & Freeman, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701442104 · Cited by 55
Tetrahymena POT1a Regulates Telomere Length and Prevents Activation of a Cell CycleCheckpoint
Jacob, N. K., Lescasse, R., Linger, B. R., & Price, C. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01975-06 · Cited by 54
Telomere and Telomerase Modulation by the Mammalian Rad9/Rad1/Hus1 DNA-Damage-Checkpoint Complex
Francia, S., Weiss, R. S., Hande, M. P., Freire, R., & di Fagagna, F. D. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.066 · Cited by 53
Elayadi, A. N., Demieville, A., Wancewicz, E. V., Monia, B. P., & Corey, D. R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.8.1683 · Cited by 53
Franceschin, M., Alvino, A., Casagrande, V., Mauriello, C., Pascucci, E., Savino, M., Ortaggi, G., & Bianco, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.11.032 · Cited by 53
Douarre, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki514 · Cited by 52
Self-citationHuang, H., Chen, I., Huang, K.-F., Lu, W.-C., Shieh, F.-Y., Huang, Y.-Y., Huang, F.-C., & Lin, J. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.284 · Cited by 51
Radiosensitization effect of zidovudine on human malignant glioma cells
Zhou, F., Liao, Z., Dai, J., Xiong, J., Xie, C., Luo, Z., Liu, S., & Zhou, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.180 · Cited by 50
Nakai, R., Ishida, H., Asai, A., Ogawa, H., Yamamoto, Y., Kawasaki, H., Akinaga, S., Mizukami, T., & Yamashita, Y. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.11.010 · Cited by 50
Gómez, D., Aouali, N., Renaud, A., Douarre, C., Shin‐ya, K., Tazi, J., Martinez, S., Trentesaux, C., Morjani, H., & Riou, J. (2003) · PubMed · Cited by 50
Self-citationInvolvement of Topoisomerase III in Telomere-Telomere Recombination
Tsai, H.-J., Huang, W., Li, T., Tsai, Y.-L., Wu, K., Tseng, S., & Teng, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600649200 · Cited by 49
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides
Li, G., Eller, M. S., Hanna, K., & Gilchrest, B. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.019 · Cited by 49
Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop
Lai, S. R., Cunningham, A. P., Huynh, V., Andrews, L. G., & Tollefsbol, T. O. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.014 · Cited by 49
Lee, S., Kim, J., Oh, S.-H., Kim, Y.-J., Rho, S.-B., Park, K.-S., Park, K. L., & Lee, J.-H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.005 · Cited by 48
Hasegawa, K., Ohashi, Y., Ishikawa, K., Yasue, A., Kato, R., Achiwa, Y., Nishio, E., & Udagawa, Y. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.5.1419 · Cited by 48
G-Quadruplex DNA binding by a series of carbocyanine dyes
Kerwin, S. M., Sun, D., Kern, J. T., Rangan, A., & Thomas, P. W. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00490-5 · Cited by 47
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines
Pizzimenti, S., Briatore, F., Laurora, S., Toaldo, C., Maggio, M., Grandi, M. D., Meaglia, L., Menegatti, E., Giglioni, B., Dianzani, M. U., et al. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.024 · Cited by 47
Pendino, F., Dudognon, C., Delhommeau, F., Sahraoui, T., Flexor, M., Griscelli, A. B., Lanotte, M., & Ségal-Bendirdjian, E. (2003) · Oncogene · doi:10.1038/sj.onc.1207093 · Cited by 47
Telomerase immunity from bench to bedside: round one
Cortez-Gonzalez, X., & Zanetti, M. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-12 · Cited by 47
p53-dependent integration of telomere and growth factor deprivation signals
Beliveau, A., Bassett, E., Lo, A. T., Garbe, J. C., Rubio, M. Á., Bissell, M. J., Campisi, J., & Yaswen, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700260104 · Cited by 46
Telomeres Limit Cancer Growth by Inducing Senescence: Long-Sought In Vivo Evidence Obtained
Sedivy, J. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.014 · Cited by 44
Patel, S. D., Isalan, M., Gavory, G., Ladame, S., Choo, Y., & Balasubramanian, S. (2004) · Biochemistry · doi:10.1021/bi048892t · Cited by 44
Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase
Alberti, P., Schmitt, P., Nguyen, C.-H., Rivalle, C., Hoarau, M., Grierson, D. S., & Mergny, J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00080-x · Cited by 43
Self-citationFranceschin, M., Pascucci, E., Alvino, A., D’Ambrosio, D., Bianco, A., Ortaggi, G., & Savino, M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.021 · Cited by 42
Compton, S. A., Elmore, L. W., Haydu, K., Jackson‐Cook, C. K., & Holt, S. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1452-1462.2006 · Cited by 41
Vitamin E suppresses telomerase activity in ovarian cancer cells
Bermudez, Y., Ahmadi, S., Lowell, N. E., & Kruk, P. A. (2007) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.12.002 · Cited by 40
Huang, H., Chou, C.-L., Guo, C.-L., Yuan, C.-L., Lu, Y.-C., Shieh, F.-Y., & Lin, J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.12.036 · Cited by 40
Targeting human telomerase for cancer therapeutics
Guittat, L., Alberti, P., Gómez, D., Cian, A. D., Pennarun, G., Lemarteleur, T., Belmokhtar, C., Boujemaa‐Paterski, R., Morjani, H., Trentesaux, C., et al. (2004) · Cytotechnology · doi:10.1007/s10616-004-5127-z · Cited by 39
Self-citationTranscriptional Repression of Telomerase RNA Gene Expression by c-Jun-NH2-Kinase and Sp1/Sp3
Bilsland, A. E., Stevenson, K. H., Atkinson, S. P., Kölch, W., & Keith, W. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1941 · Cited by 37
Zhao, J., Bilsland, A. E., Hoare, S. F., & Keith, W. N. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00038-3 · Cited by 36
Cerone, M. A., Londoño‐Vallejo, A., & Autexier, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209727 · Cited by 36
Telomerase-based immunotherapy of cancer
Carpenter, E. L., & Vonderheide, R. H. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.10.1031 · Cited by 35
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor
Wu, P., Li, M., Wang, H., Zhou, J., Xu, G., Wang, S., Xi, L., Chen, G., Wang, B., Zhu, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.039 · Cited by 34
Heald, R. A., & Stevens, M. F. G. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b305177n · Cited by 33
Allosteric inhibitors of telomerase: oligonucleotide N3'->P5' phosphoramidates
Pruzan, R., Pongracz, K., Gietzen, K., Wallweber, G., & Gryaznov, S. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.2.559 · Cited by 33
Genetic Analysis of Myc and Telomerase Interactions In Vivo
Flores, I., Evan, G., & Blasco, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00543-06 · Cited by 33
Cancer immunotherapy targeting the telomerase reverse transcriptase.
Huo, L.-F., Tang, J. W., Huang, J. J., Huang, P. T., Huang, C. F., Kung, H. F., & Lin, M. C. M. (2006) · PubMed · Cited by 31
Pendino, F., Sahraoui, T., Lanotte, M., & Ségal-Bendirdjian, E. (2002) · Leukemia · doi:10.1038/sj.leu.2402470 · Cited by 31
Telomere maintenance in clinical medicine
Ulaner, G. A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.048 · Cited by 28
Highlights in experimental therapeutics
Burger, A. M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.03.012 · Cited by 28
Hansen, N., Wylie, R. C., Phipps, S. M. O., Love, W. K., Andrews, L., & Tollefsbol, T. O. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.3.641 · Cited by 28
Ohashi, N., Yaar, M., Eller, M. S., Truzzi, F., & Gilchrest, B. A. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20848 · Cited by 26
Telomeres rather than telomerase a key target for anti‐cancer therapy?
Boukamp, P., & Mirancea, N. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00517.x · Cited by 26
Cancer Immunotherapy Targeting the Telomerase Reverse Transcriptase
Longfei, Huo, Janice, J., et al. (2006) · 中国免疫学杂志:英文版 · Cited by 26
Shammas, M. A., Liu, X., Gavory, G., Raney, K. D., Balasubramanian, S., & Reis, R. J. S. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.003 · Cited by 25
Choi, Y. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.5.1207 · Cited by 25
Furuta, M., Nozawa, K., Takemura, M., Izuta, S., Murate, T., Tsuchiya, M., Yoshida, K., Taka, N., Nimura, Y., & Yoshida, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11022 · Cited by 24
Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzymea
Colangelo, D., Ghiglia, A. L., Viano, I., Cavigiolio, G., & Osella, D. (2003) · BioMetals · doi:10.1023/a:1023428315746 · Cited by 23
The telomerase inhibitor telomestatin induces telomere shortening and cell death in Arabidopsis
Zhang, L., Tamura, K., Shin‐ya, K., & Takahashi, H. K. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.12.002 · Cited by 22
Park, C., Kim, G., Kim, W. I., Hong, S. H., Park, D. I., Kim, N. D., Bae, S.-J., Jung, J. H., & Choi, Y. H. (2007) · Chemotherapy · doi:10.1159/000100809 · Cited by 21
Pendino, F., Hillion, J., Dudognon, C., Delaunay, J., Mourah, S., Podgorniak, M.-P., Lafon, I., Chomienne, C., Lanotte, M., Dombret, H., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404127 · Cited by 19
Specific alkylation of human telomere repeats by hairpin pyrrole-imidazole polyamide
Takahashi, R., Bando, T., & Sugiyama, H. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00176-7 · Cited by 17
Lindkvist, A., Ivarsson, K., Jernberg‐Wiklund, H., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.068 · Cited by 16
Tumour‐cell apoptosis after cisplat in treatment is not telomere dependent
Jeyapalan, J. C., Saretzki, G. C., Leake, A., Tilby, M. J., & von Zglinicki, T. (2005) · International Journal of Cancer · doi:10.1002/ijc.21675 · Cited by 16
Receptor Ck-dependent signaling regulates hTERT gene transcription
Sikand, K., Kaul, D., & Varma, N. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-2 · Cited by 15
Need telomere maintenance? Call 911
Francia, S., Weiss, R. S., & di Fagagna, F. D. (2007) · Cell Division · doi:10.1186/1747-1028-2-3 · Cited by 14
Diagnostics, Prognostic and Therapeutic Exploitation of Telomeres and Telomerase in Leukemias
Deville, L., Hillion, J., Lanotte, M., et al. (2006) · Current Pharmaceutical Biotechnology · doi:10.2174/138920106777549768 · Cited by 13
Rad54 is dispensable for the ALT pathway
Akiyama, K., Yusa, K., Hashimoto, H., Poonepalli, A., Hande, M. P., Kakazu, N., Takeda, J., Tachibana, M., & Shinkai, Y. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.01020.x · Cited by 8
Telomerase inhibition as an adjuvant anticancer therapy: it is more than just a waiting game
Elmore, L. W., & Holt, S. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.4.427 · Cited by 4
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro
Carbonare, L. D., Valenti, M. T., Bertoldo, F., Fracalossi, A., Balducci, E., Azzarello, G., Vinante, O., & Cascio, V. L. (2007) · Aging Clinical and Experimental Research · doi:10.1007/bf03324673 · Cited by 3
Cited by
Circular dichroism and conformational polymorphism of DNA
Kypr, J., Kejnovska, I., Renciuk, D., & Vorlickova, M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp026 · Cited by 1,774
A hitchhiker's guide to G-quadruplex ligands
Monchaud, D., & Teulade-Fichou, M.-P. (2008) · Org. Biomol. Chem. · doi:10.1039/b714772b · Cited by 788
Re-evaluation of G-quadruplex propensity with G4Hunter
Bedrat, A., Lacroix, L., & Mergny, J.-L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw006 · Cited by 687
Self-citationMetal Cations in G-Quadruplex Folding and Stability
Bhattacharyya, D., Mirihana Arachchilage, G., & Basu, S. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00038 · Cited by 621
The application of DNA and RNA G-quadruplexes to therapeutic medicines
Collie, G. W., & Parkinson, G. N. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15067g · Cited by 589
Metadata
- Authors
- De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L.
- Venue
- Biochimie
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 90
- Issue
- 1
- Pages
- 131-155
- ISSN
- 0037-9042 (ISSN-L)
- 0300-9084
- OpenAlex
- W2092324565
- Cited by
- 572
- References
- 314
- FWCI
- 30.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.